Header Logo

Connection

Christopher Aston to Alzheimer Disease

This is a "connection" page, showing publications Christopher Aston has written about Alzheimer Disease.
Connection Strength

0.186
  1. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Neurosci Lett. 1999 Mar 26; 263(2-3):129-32.
    View in: PubMed
    Score: 0.034
  2. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat Genet. 1998 Mar; 18(3):211-2.
    View in: PubMed
    Score: 0.032
  3. Association between ACT polymorphism and Alzheimer's disease. Neurology. 1998 Feb; 50(2):574-6.
    View in: PubMed
    Score: 0.032
  4. Re: Genetic effect of alpha 1-antichymotrypsin on the risk of Alzheimer disease. Genomics. 1997 Mar 01; 40(2):382-5.
    View in: PubMed
    Score: 0.030
  5. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet Epidemiol. 1997; 14(2):169-80.
    View in: PubMed
    Score: 0.029
  6. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin. Ann N Y Acad Sci. 1996 Dec 16; 802:27-34.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.